Agenda for Day 1 - Thursday, September 24th, 2026Thursday, 24 September 2026 - ET (Eastern Time, GMT-05:00)

• Gain insights and tools to help navigate evolving market conditions and lead through uncertainty
• Evaluate how inflation, interest rates, and pricing initiatives could affect biotech revenue expectations, margins, capital availability and strategic planning through 2027 and beyond
• Assess how producer prices for U.S. human biologics are changing and identify future pricing trajectories
• Develop a broad view of business cycle changes and sector-level drivers to identify risks and opportunities, aligning strategy, budgeting, and investments while influencing financial reporting decisions with forward-looking economic insight

CPE Credits Available: 1.2

• Explore how to operationalize recent regulatory changes, including practical strategies for adapting to the FASB’s disaggregation standard (DISE), potential impacts on financial reporting and compliance with evolving audit and reporting requirements
• Gain insights into leveraging AI tools and systems to streamline processes, enhance accuracy and efficiency, prepare for commercialization and enable scalability
• Hear lessons learned from transitioning from clinical to commercial operations, including inventory management, government pricing and supply chain complexities
• Discuss approaches to talent development, workload management and fostering adaptability in lean finance teams

CPE Credits Available: 1.4

• Hear directly from governing bodies as they provide critical updates on SEC and FASB reporting standards
• Understand the significant implications of these changes and how they may impact your organization’s compliance and financial reporting strategies

CPE Credits Available: 1.4

• Discover how to strategically position your organization to attract investors and secure funding to ensure cash flow in a competitive and evolving financial landscape
• Understand SOX-compliant internal control frameworks, critical accounting policies and technical accounting considerations for equity financing and partnership transactions that demonstrate financial readiness to investors
• Learn practical approaches to securing partnerships, navigating M&A due diligence costs, and building scalable systems for financial growth
• Gain insights into crafting compelling investment narratives and optimizing investor communication to capitalize on future funding events

CPE Credits Available: 1.2

• Explore strategies to optimize operations and preserve cash runway through automation and cost-effective, scalable systems
• Learn best practices for integrating compliance reporting responsibilities into lean operations while ensuring accurate financial reporting and audit readiness
• Discover approaches to right-size organizations, including strategic cost allocation for ERP systems and audits while building resilient teams
• Gain insights from real-world examples and finance leaders on navigating resource constraints

CPE Credits Available: 1.2

• Develop robust financial models and forecasting strategies to support the transition from pre-commercial to commercial phases
• Evaluate market opportunities and ROI to assess launch feasibility and financial sustainability
• Prepare for regulatory, supply chain, and operational requirements to meet the demands of a successful product launch
• Gain practical insights into cross-functional alignment and resource optimization to ensure launch excellence
• Learn from real-world case studies on overcoming common pitfalls in commercialization, including managing overhead costs, VAT compliance, and trade regulations

CPE Credits Available: 1.2

This open forum allows senior-level executives to exchange ideas and best practices for driving internal and organizational success through efficiencies, technology and new innovations.

*Attendees must be Head of/VP/C-Suite-level and currently employed by a life sciences manufacturer. Informa reserves the right to qualify participants for this session.

CPE Credits Available: 1.2